(1) A cannabinoid product label shall legibly display the following information:
- (a) product name or common name, on the front of the label;
- (b) brand name, on the front of the label;
- (c) the size of the container or net count of individual items, on the front of the label;
- (d) the suggested use of the product, including serving size if the product is intended for consumption;
(e) list of ingredients, including:
- (i) the amount of any advertised cannabinoid listed as present on the COA; and
- (ii) the amount of any THC or any THC analog listed as present on the COA;
- (f) manufacturer, packer, or distributor name and address, as verified through the application; and
- (g) batch number.
- (2) The label of each product intended for human consumption or intended to be vaporized for inhalation shall include the following text, prominently displayed: "This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." or a similar statement.
- (3) In addition to the requirements of Subsections R66-35-5(1) through R66-35-5(5), a cannabinoid product label shall include a scannable barcode, QR code, or web address with an easily located COA for the batch identified, containing the information required in Section R66-35-4.
- (4) Cannabinoid products may not contain medical claims on the label.
(5) Cannabinoid product labeling may not:
- (a) have any likeness bearing resemblance to a cartoon character or fictional character; or
- (b) appear to imitate a food or other product that is typically marketed toward or appealing to children.
- (6) A cannabinoid product is misbranded if its label is false or misleading in any way.
KEY: CBD labeling, CBD products, cannabinoid product registration; cannabinoid product labeling; cannabinoid testing, cannabinoid COA; violations
Date of Last Change: October 10, 2025
Authorizing, and Implemented or Interpreted Law: 4-41-403(1); 4-41-402(2); 4-41-103(4)